Patents by Inventor David Edward Watson

David Edward Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-glucagon antibodies and uses thereof
    Patent number: 9453073
    Abstract: Provided are monoclonal antibodies, or antigen-binding fragments thereof, that bind to glucagon. These antibodies are useful in immunoassays of glucagon levels, and/or in vivo, ex vivo or in vitro immunochemical and other imaging methods for detecting glucagon levels, and for diagnostic, prognostic and predictive purposes, and for optimizing therapeutic regimens in patients in which glucagon signaling is implicated in pathogenesis.
    Type: Grant
    Filed: November 27, 2012
    Date of Patent: September 27, 2016
    Assignee: Eli Lilly and Company
    Inventors: David Edward Watson, Robert W. Siegel, Nan Jia, John Harrison Sloan
  • ANTI-GLUCAGON ANTIBODIES AND USES THEREOF
    Publication number: 20140335096
    Abstract: Provided are monoclonal antibodies, or antigen-binding fragments thereof, that bind to glucagon. These antibodies are useful in immunoassays of glucagon levels, and/or in vivo, ex vivo or in vitro immunochemical and other imaging methods for detecting glucagon levels, and for diagnostic, prognostic and predictive purposes, and for optimizing therapeutic regimens in patients in which glucagon signaling is implicated in pathogenesis.
    Type: Application
    Filed: November 27, 2012
    Publication date: November 13, 2014
    Inventors: David Edward Watson, Robert W. Siegel, Nan Jia, John Harrison Sloan